Cargando…
Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination
Autores principales: | Inaba, Tohru, Okumura, Keita, Maekura, Chika, Muramatsu, Ayako, Kobayashi, Tsutomu, Kuroda, Junya, Nukui, Yoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070610/ https://www.ncbi.nlm.nih.gov/pubmed/35513761 http://dx.doi.org/10.1007/s12185-022-03376-y |
Ejemplares similares
-
Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination
por: Inaba, Tohru, et al.
Publicado: (2022) -
Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature
por: Maekura, Chika, et al.
Publicado: (2022) -
Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti–SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms
por: Onishi, Akio, et al.
Publicado: (2023) -
Seroreactivity to Dirofilaria antigens in people from different areas of Serbia
por: Tasić-Otašević, Suzana A, et al.
Publicado: (2014) -
Seroreactivity to Q Fever Among Slaughterhouse Workers in South Korea
por: Chu, Hyuk, et al.
Publicado: (2017)